Antibacterial effect via competitive exclusion by oral probiotics

This "target" refers broadly to the mechanism whereby orally administered probiotics exert antibacterial effects through competition with pathogenic bacteria for ecological niches, nutrients, and attachment sites in the oral cavity. By colonizing oral surfaces, probiotics such as Lactobacillus, Bifidobacterium, and specific Streptococcus strains can reduce levels of oral pathogens (e.g., Streptococcus mutans, Porphyromonas gingivalis, Candida albicans[1][2][5]), inhibit biofilm formation, and produce antimicrobial substances that suppress pathogen growth[1][2][5]. Additionally, certain strains may modulate host immune responses and contribute to prevention of oral diseases including dental caries, gingivitis, periodontitis, and halitosis[1][2][3][4][5]. The main mechanistic feature is competitive exclusion, not action on a single target molecule, so this entry should not be considered a canonical molecular target. If you require structured entries for specific molecules or proteins involved in these probiotic effects (e.g., bacteriocins, adhesion proteins), please specify an individual molecule, as this entry covers a complex, multistrain ecological mechanism and not a defined receptor, enzyme, or transporter.

Other names

Probiotic competitive exclusion in oral cavityOral probiotic antagonismMicrobial competition in oral microbiomeProbiotic-mediated pathogen inhibition

Competitive exclusion (probiotics outcompete pathogens for niche, nutrients, and attachment); Production of antimicrobials (bacteriocins, hydrogen peroxide, fatty acids); Immune modulation (stimulating host immune defenses); Biofilm inhibition (disruption of pathogenic biofilms)